Follow-up of rheumatic carditis treated with steroids

Gesmar V H Herdy1, Rafael S Gomes, Anna E A Silva

  • 1Departamento de Pediatria da Faculdade de Medicina, Universidade Federal Fluminense, Travessa Antonio Pedro 10/301, Niteroi, Rio de Janeiro CEP-24230030, Brazil. gesmarhaddad@uol.com.br

Cardiology in the Young
|October 22, 2011
PubMed

Insights

Long-term follow-up of children with severe rheumatic carditis treated with corticosteroids shows that adherence to secondary prophylaxis is crucial. Neglecting prophylaxis led to serious sequelae and high recurrence rates, impacting long-term outcomes.

Area of Science:

  • Pediatrics
  • Cardiology
  • Rheumatology

Background:

  • Severe rheumatic carditis in children poses significant long-term health risks.
  • Corticosteroid therapy is a common treatment for rheumatic carditis.
  • Long-term outcomes and the impact of secondary prophylaxis require further investigation.

Purpose of the Study:

  • To evaluate the long-term outcomes of children hospitalized for severe rheumatic carditis treated with corticosteroids.
  • To assess the impact of secondary prophylaxis adherence on patient sequelae and recurrence.

Main Methods:

  • Retrospective analysis of 242 children with severe rheumatic carditis.
  • Follow-up of 118 patients for an average of 7.7 years.
  • Treatment included antibiotics and either intravenous methylprednisolone or oral prednisone.

Main Results:

  • Valve involvement (mitral and/or aortic) was common, with varying patterns between treatment groups.
  • Rupture of chordae tendineae occurred in 68% of first-attack patients.
  • 49% of patients experienced carditis recurrence due to neglected secondary prophylaxis, leading to re-hospitalization.
  • 33% had a favorable outcome, while 6.8% mortality was observed.

Conclusions:

  • Adherence to secondary prophylaxis is critical for preventing serious sequelae and recurrence in children with rheumatic carditis.
  • Neglect or abandonment of prophylaxis significantly increases the risk of severe complications.
  • High rates of abandonment and loss to follow-up were observed, highlighting challenges in long-term management.
Abstract

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...